BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7558438)

  • 1. Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid.
    Hill SA; Sampson LE; Chaplin DJ
    Int J Cancer; 1995 Sep; 63(1):119-23. PubMed ID: 7558438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of mitomycin-C cytotoxicity by combination with flavone acetic acid in a murine tumour.
    Parkins CS; Denekamp J; Chaplin DJ
    Anticancer Res; 1993; 13(5A):1437-42. PubMed ID: 8239516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of chlorambucil cytotoxicity by combination with flavone acetic acid in a murine tumour.
    Parkins CS; Chadwick JA; Chaplin DJ
    Anticancer Res; 1994; 14(4A):1603-8. PubMed ID: 7979193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action.
    Hill S; Williams KB; Denekamp J
    Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1419-24. PubMed ID: 2591434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.
    Chaplin DJ; Pettit GR; Parkins CS; Hill SA
    Br J Cancer Suppl; 1996 Jul; 27():S86-8. PubMed ID: 8763854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinca alkaloids: anti-vascular effects in a murine tumour.
    Hill SA; Lonergan SJ; Denekamp J; Chaplin DJ
    Eur J Cancer; 1993; 29A(9):1320-4. PubMed ID: 8343277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavone acetic acid induces a coagulopathy in mice.
    Murray JC; Smith KA; Thurston G
    Br J Cancer; 1989 Nov; 60(5):729-33. PubMed ID: 2803949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
    Baguley BC; Zhuang L; Kestell P
    Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Thomsen LL; Baguley BC; Wilson WR
    Cancer Chemother Pharmacol; 1992; 31(2):151-5. PubMed ID: 1451234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant treatment does not affect the action of flavone acetic acid in tumour-bearing mice.
    Thurston G; Smith KA; Murray JC
    Br J Cancer; 1991 Oct; 64(4):689-92. PubMed ID: 1911218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor-alpha plasma levels after flavone acetic acid administration in man and mouse.
    Chabot GG; Branellec D; Sassi A; Armand JP; Gouyette A; Chouaib S
    Eur J Cancer; 1993; 29A(5):729-33. PubMed ID: 8471332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavone acetic acid potentiates the induction of endothelial procoagulant activity by tumour necrosis factor.
    Murray JC; Smith KA; Stern DM
    Eur J Cancer; 1991; 27(6):765-70. PubMed ID: 1829921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.
    Bibby MC; Phillips RM; Double JA; Pratesi G
    Br J Cancer; 1991 Jan; 63(1):57-62. PubMed ID: 1989665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoacting agents flavone acetic acid and hydralazine given in combination enhance antitumor effects under condition of hyperthermia.
    Yamamoto M; Kusumoto T; Endo K; Baba H; Sakaguchi Y; Maehara Y; Sugimachi K
    Oncology; 1996; 53(2):147-52. PubMed ID: 8604241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512).
    Bibby MC; Phillips RM; Double JA
    Cancer Chemother Pharmacol; 1989; 24(2):87-94. PubMed ID: 2731316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma.
    Sun JR; Brown JM
    Cancer Res; 1989 Oct; 49(20):5664-70. PubMed ID: 2790784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid.
    Pratesi G; Rodolfo M; Rovetta G; Parmiani G
    Eur J Cancer; 1990; 26(10):1079-83. PubMed ID: 2148884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo interaction between flavone acetic acid and hyperthermia.
    Horsman MR; Sampson LE; Chaplin DJ; Overgaard J
    Int J Hyperthermia; 1996; 12(6):779-89. PubMed ID: 8950158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Baguley BC; Cole G; Thomsen LL; Li Z
    Cancer Chemother Pharmacol; 1993; 33(1):77-81. PubMed ID: 8269593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice.
    Chabot GG; Bissery MC; Corbett TH; Rutkowski K; Baker LH
    Cancer Chemother Pharmacol; 1989; 24(1):15-22. PubMed ID: 2597279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.